dr leigh show-header

Risks for Women after PCI Heart Surgery

Summary: Women are at risk of worse outcomes among young people undergoing percutaneous coronary intervention (PCI).
Air Date: 3/11/16
Duration: 10
Host: Leigh Vinocur, MD
Guest Bio: Robert L. Wilensky, MD
Dr. Robert WilenskyRobert L. Wilensky is Professor of Medicine, Director of Interventional Cardiology Research and Director of the Interventional Cardiology Fellowship Program at the University of Pennsylvania. His research interests include acute coronary syndromes, diagnosis and treatment of vulnerable coronary lesions, and diabetic arteriopathy. Dr. Wilensky received his MD degree with distinction from the University of Amsterdam.  His internship and residency in Internal Medicine were obtained at the Georgetown University Medical Center/VAMC in Washington, DC. His fellowship in Cardiology was at the Krannert Institute of Cardiology, Indiana University, where he was Chief Fellow and later Assistant Professor of Medicine. He joined the faculty of the University of Pennsylvania in 1996. Dr. Wilensky has been an active organizer of and participant in numerous international cardiology symposia and has lectured both domestically and internationally. He is a Fellow of the American College of Cardiology and the Society of Angiography and Coronary Intervention. He is the author or co-author of over 200 papers and has four patents.


Risks for Women after PCI Heart Surgery
Women are at risk of worse outcomes among young people undergoing percutaneous coronary intervention (PCI).

PCI is angioplasty with stent, a non-surgical procedure that uses a catheter to place a stent in the heart to open up blood vessels that have been narrowed by plaque buildup.

Factors that may influence the risk of target vessel and target lesion failure in women include depression, estrogen state, inflammation, and underlying hematologic and rheumatologic disorders.

Listen in as Dr. Robert Willensky discusses the findings of a recent study on these effects.

Comments

FREE RadioMD Newsletter: